SBFM has 36-month beta value of 0.38. Analysts have mixed views on the stock, with 1 analysts rating it as a “buy,” 0 as “overweight,” 0 as “hold,” and 0 as “sell.”
The public float for SBFM is 2.71M, and currently, short sellers hold a 4.17% ratio of that float. The average trading volume of SBFM on April 02, 2025 was 66.12K shares.
SBFM) stock’s latest price update
Sunshine Biopharma Inc (NASDAQ: SBFM)’s stock price has gone rise by 8.90 in comparison to its previous close of 1.91, however, the company has experienced a -2.35% decrease in its stock price over the last five trading days. accessnewswire.com reported 2025-04-01 that FORT LAUDERDALE, FL / ACCESS Newswire / April 1, 2025 / Sunshine Biopharma Inc. (NASDAQ:SBFM) (the “Company”), a pharmaceutical company offering and researching life-saving medicines in a variety of therapeutic areas including oncology and antivirals today announced that it has filed its 2024 annual report on Form 10-K on Tuesday, April 1, 2025. The following are highlights of the report: Revenue in 2024 grew to $34.9 million, a 45% increase over 2023 revenue of $24.1 million.
SBFM’s Market Performance
Sunshine Biopharma Inc (SBFM) has seen a -2.35% fall in stock performance for the week, with a -9.96% decline in the past month and a -32.03% plunge in the past quarter. The volatility ratio for the week is 7.32%, and the volatility levels for the past 30 days are at 8.23% for SBFM. The simple moving average for the past 20 days is -2.69% for SBFM’s stock, with a -39.80% simple moving average for the past 200 days.
SBFM Trading at -13.36% from the 50-Day Moving Average
After a stumble in the market that brought SBFM to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -99.22% of loss for the given period.
Volatility was left at 8.23%, however, over the last 30 days, the volatility rate increased by 7.32%, as shares sank -2.76% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -28.24% lower at present.
During the last 5 trading sessions, SBFM fell by -2.35%, which changed the moving average for the period of 200-days by -63.53% in comparison to the 20-day moving average, which settled at $2.1400. In addition, Sunshine Biopharma Inc saw -30.67% in overturn over a single year, with a tendency to cut further losses.
Stock Fundamentals for SBFM
Current profitability levels for the company are sitting at:
- -0.14 for the present operating margin
- 0.3 for the gross margin
The net margin for Sunshine Biopharma Inc stands at -0.13. The total capital return value is set at -0.18. Equity return is now at value -17.98, with -14.65 for asset returns.
Based on Sunshine Biopharma Inc (SBFM), the company’s capital structure generated 0.02 points at debt to capital in total, while cash flow to debt ratio is standing at -21.23. The debt to equity ratio resting at 0.02. The interest coverage ratio of the stock is -58.12.
Currently, EBITDA for the company is -5.15 million with net debt to EBITDA at 2.9. When we switch over and look at the enterprise to sales, we see a ratio of -0.18. The receivables turnover for the company is 10.24for trailing twelve months and the total asset turnover is 1.1. The liquidity ratio also appears to be rather interesting for investors as it stands at 5.74.
Conclusion
To put it simply, Sunshine Biopharma Inc (SBFM) has had a bad performance in recent times. Analysts have a bullish opinion on the stock, with some rating it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
